Wilmington, MA March 14, 2016—Micro Medical Solutions announces it has received European CE Mark approval for two of its key innovations. “This approval paves the way for the final stage of development for our proprietary Micro Vascular Integrated Platform,” said Gregory Sullivan, CEO of Micro Medical Solutions. The Micro Vascular Integrated Platform (mVIP) will include the MicroBalloon and MicroGuide, designed for treatment of critical limb ischemia (CLI) lesions that are Below the Knee (BTK). 510K approvals for the MicroGuide and MicroBalloon were competed recently, and 510K approval and CE Mark for the components of the platform are expected to follow in 2017.

CONTACT: Peg Thornton, Director of Corporate and Market Development, Micro Medical Solutions 732-616-9123